// App-Quantinova.ai

1144 : Variable Reduction Of Thrombus Formation In The Blood Of Patients Treated With Oral Factor Xa and Thrombin Inhibitors: Pathophysiologic and Therapeutic Implications

Researchers

Presenter

  • Grazia Loredana Mendolicchio

Principal Investigators

  • Patrizia Marchese

  • Corrado Lodigiani

  • Anna Colombo

  • Matteo Ferrari

  • Marco Scardino

  • Guido Grappiolo

  • Lidia Rota

  • Zaverio M Ruggeri

Medical Centers

  • Centro Trombosi, IRCCS Istituto Clinico Humanitas, Rozzano Milano, Italy

  • Centro Ortopedia del-Anca e Chirurgia Protesica, IRCCS Istituto Clinico Humanitas, Rozzano Milano, Italy

  • Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Deep vein thrombosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • Evithrom

  • Warfarin

Outcome

  • N/A

Study Design

  • fixed dose

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved